In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
In a new opinion piece, Reps. Albio Sires (D-NJ) and Mario Diaz-Balart (R-FL) write about the need to sustain US investments in research and development for global health tools to prevent the spread of disease both in the United States and abroad.
The International Federation of Pharmaceutical Manufacturers & Associations is calling for increased public-private sector engagement to accelerate progress toward the Millennium Development Goals. The group is also stressing that partnerships be central components of the post-2015 development agenda.
Rep. Barbara Lee (D-CA) recently introduced a bill that aims to stop the spread of HIV around the world. The bill, called the Ending the HIV/AIDS Epidemic Act of 2013 (HR 3117), includes a focus on research to create new HIV/AIDS treatment and prevention tools.
A new investment fund launched this week that will allow individuals and institutional investors the opportunity to finance the development of late-stage global health technologies.
The HOOKVAC consortium has been awarded a grant from the European Commission to expand the Sabin Vaccine Institute Product Development Partnership’s work to develop and test a vaccine for human hookworm. Under the grant, the HOOKVAC consortium will begin the first clinical testing of the human hookworm vaccine in the West African nation of Gabon.